Listar por tema "Fasciola"

Mostrando ítems 1-8 de 8

Association of Fasciola hepatica Infection with Liver Fibrosis, Cirrhosis, and Cancer: A Systematic Review

Machicado Rivero, Claudia Inés Gloria; Machicado, Jorge-D.; Maco, Vicente; Terashima, Angelica; Marcos, Luis-A. (Public Library of Science, 2016)

BACKGROUND: Fascioliasis has been sporadically associated with chronic liver disease on previous studies. In order to describe the current evidence, we carried out a systematic review to assess the association between ...
Citocinas en plasma durante fasciolosis humana aguda

Aron Said, Catalina (Universidad Peruana Cayetano HerediaPE, 2024)

La fascioliasis es una trematodiasis de transmisión alimentaria con distribución mundial. Los niños menores de 15 años presentan la prevalencia más alta de infección. Hipotetizamos que la fascioliasis aguda está asociada ...
Geospatial analysis of the associations between environmental contamination with livestock feces and children with chronic fascioliasis in the Anta province of Cusco, Peru

Tanabe, M.B.; Prochaska, J.; Morales Fernández, María Luisa; Lopez, Martha; Baca-Turpo, Benicia; Arque, Eulogia; Cabada, Miguel Mauricio (Public Library of Science, 2022)

Fasciola hepatica is a neglected parasitic infection with significant human health and livestock industry impact. The Andean Altiplano harbors an estimated 50% of the Fasciola's world infection burden. There is scarce data ...
Hypothetical granulin-like molecule from Fasciola hepatica identified by bioinformatics analysis

Machicado Rivero, Claudia Inés Gloria; Marcos, Luis-A.; Zimic-Peralta, Mirko Juan (Springer, 2016)

Fasciola hepatica is considered an emergent human pathogen, causing liver fibrosis or cirrhosis, conditions that are known to be direct causes of cancer. Some parasites have been categorized by WHO as carcinogenic agents ...
Observational study on the effectiveness and safety of multiple regimens of triclabendazole in human fascioliasis after failure to standard-of-care regimens.

Terashima, Angélica; Canales, Marco; Maco, Vicente; Marcos, Luis A. (Elsevier, 2021)

OBJECTIVES: Triclabendazole (TCBZ) is the recommended anthelmintic against Fasciola hepatica at a dose of 10 mg/kg body weight administered as a single or double dose. However, treatment failures to TCBZ standard-of-care ...
Plasma cytokines during acute human fascioliasis

Aron-Said, Catalina; Montes Delgado, Martin; White Jr, A. Clinton; Cabada, Miguel M. (Springer Verlag, 2021)

Fascioliasis is a foodborne trematode endemic worldwide. Children under 15 years have the highest prevalence of infection. We hypothesized that acute fascioliasis would be associated with more pronounced cytokine changes ...
Stunting in pre-school and school-age children in the peruvian highlands and its association with fasciola infection and demographic factors

Webb, C.M.; Morales Fernández, María Luisa; Lopezid, M.; Baca-Turpo, B.; Arque, E.; White, A.C., Jr.; Cabada, M.M. (Public Library of Science, 2021)

Fascioliasis is a zoonotic trematode infection that is endemic in the highlands of Peru. Chronic fascioliasis can be asymptomatic and remain undiagnosed for years. Chronic malnutrition in children, as manifested by stunting, ...
Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures

Marcos, L.; Maco, V.; Terashima, A. (Taylor and Francis, 2021)

Introduction: The only drug effective against the infection caused by Fasciola hepatica or F. gigantica is triclabendazole (TCBZ), recommended by the WHO and recently approved by the FDA. Here, we describe the evolution ...

Listar por tema "Fasciola"

Listar por tema "Fasciola"

Buscar en el Repositorio

Listar

Todo el Repositorio

Panel de Control